145 related articles for article (PubMed ID: 29538035)
1. Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.
Pan Q; Luo Y; Cao X; Ma Y; Li F
Clin Nucl Med; 2018 Jun; 43(6):462-463. PubMed ID: 29538035
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Cryptococcosis Accidentally Detected by 68Ga-Pentixafor PET/CT in a Patient With Multiple Myeloma.
Pan Q; Luo Y; Cao X; Li J; Li F
Clin Nucl Med; 2020 May; 45(5):423-425. PubMed ID: 32209881
[TBL] [Abstract][Full Text] [Related]
3. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Luo Y; Pan Q; Feng J; Cao X; Li F
Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
[TBL] [Abstract][Full Text] [Related]
4. Increased Uptake of 68Ga-Pentixafor in Thymic Rebound After Chemotherapy in a Patient With Multiple Myeloma.
Pan Q; Luo Y; Cao X; Li J
Clin Nucl Med; 2021 Jan; 46(1):90-92. PubMed ID: 33181744
[TBL] [Abstract][Full Text] [Related]
5. Chemokine Receptor 4-Targeted PET/CT With 68 Ga-Pentixather Detects More Lesions Than 68 Ga-Pentixafor PET/CT in Multiple Myeloma.
Yang Q; Zhang F; Hao Z; Zhuang J; Huo L
Clin Nucl Med; 2024 Jun; 49(6):592-593. PubMed ID: 38630995
[TBL] [Abstract][Full Text] [Related]
6. [
Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1926-1936. PubMed ID: 38286937
[TBL] [Abstract][Full Text] [Related]
7. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.
Kuyumcu S; Yilmaz E; Büyükkaya F; Özkan ZG; Ünal SN
Clin Nucl Med; 2018 Aug; 43(8):606-608. PubMed ID: 29916918
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor-4 targeted PET/CT with
Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
[TBL] [Abstract][Full Text] [Related]
9. [
Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-Pentixafor PET/CT Improves the Detection of Recurrent Myeloma in the Temporal Bone Masked by the Physiological 18F-FDG Uptake of the Brain and Extraocular Muscles.
Pan Q; Luo Y; Cao X; Li J
Clin Nucl Med; 2022 Apr; 47(4):e348-e350. PubMed ID: 35020649
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Superscan on 18F-FDG PET/CT in a Patient With Multiple Myeloma.
Fu Z; Chen X; Yang X; Li Q
Clin Nucl Med; 2019 Feb; 44(2):169-170. PubMed ID: 30516669
[TBL] [Abstract][Full Text] [Related]
12. Reduced splenic uptake on
Kraus S; Klassen P; Kircher M; Dierks A; Habringer S; Gäble A; Kortüm KM; Weinhold N; Ademaj-Kospiri V; Werner RA; Schirbel A; Buck AK; Herhaus P; Wester HJ; Rosenwald A; Weber WA; Einsele H; Keller U; Rasche L; Lapa C
Theranostics; 2022; 12(13):5986-5994. PubMed ID: 35966583
[TBL] [Abstract][Full Text] [Related]
13. Posttreated POEMS Syndrome With Concurrent Follicular Lymphoma Revealed by 18F-FDG and 68Ga-Pentixafor PET/CT.
Pan Q; Luo Y; Cao X; Li J; Li F
Clin Nucl Med; 2020 Mar; 45(3):220-222. PubMed ID: 31977484
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
Herrmann K; Lapa C; Wester HJ; Schottelius M; Schiepers C; Eberlein U; Bluemel C; Keller U; Knop S; Kropf S; Schirbel A; Buck AK; Lassmann M
J Nucl Med; 2015 Mar; 56(3):410-6. PubMed ID: 25698782
[TBL] [Abstract][Full Text] [Related]
15. Intense 68Ga-Pentixafor Activity in Aldosterone-Producing Adrenal Adenomas.
Ding J; Tong A; Zhang Y; Wen J; Huo L
Clin Nucl Med; 2020 Apr; 45(4):336-339. PubMed ID: 32108693
[TBL] [Abstract][Full Text] [Related]
16. Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on
Xu L; Tetteh G; Lipkova J; Zhao Y; Li H; Christ P; Piraud M; Buck A; Shi K; Menze BH
Contrast Media Mol Imaging; 2018; 2018():2391925. PubMed ID: 29531504
[TBL] [Abstract][Full Text] [Related]
17. Chemokine Receptor 4 Expression in Primary Sjögren's Syndrome.
Cytawa W; Kircher S; Schirbel A; Shirai T; Fukushima K; Buck AK; Wester HJ; Lapa C
Clin Nucl Med; 2018 Nov; 43(11):835-836. PubMed ID: 30179908
[TBL] [Abstract][Full Text] [Related]
18. Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
Chen Z; Xue Q; Huang C; Yao S; Miao W
Clin Nucl Med; 2022 Jan; 47(1):98-100. PubMed ID: 34115701
[TBL] [Abstract][Full Text] [Related]
19.
Bouter C; Meller B; Sahlmann CO; Staab W; Wester HJ; Kropf S; Meller J
J Nucl Med; 2018 Feb; 59(2):320-326. PubMed ID: 28729430
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG.
Derlin T; Jonigk D; Bauersachs J; Bengel FM
Clin Nucl Med; 2016 Apr; 41(4):e204-5. PubMed ID: 26756098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
